1. Home
  2. IX vs RMD Comparison

IX vs RMD Comparison

Compare IX & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orix Corp Ads

IX

Orix Corp Ads

SELL

Current Price

$36.84

Market Cap

39.5B

Sector

Finance

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

SELL

Current Price

$238.42

Market Cap

34.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IX
RMD
Founded
1950
1989
Country
Japan
United States
Employees
N/A
N/A
Industry
Diversified Financial Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5B
34.0B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
IX
RMD
Price
$36.84
$238.42
Analyst Decision
Buy
Analyst Count
0
20
Target Price
N/A
★ $251.99
AVG Volume (30 Days)
243.9K
★ 967.2K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
★ 2.05%
1.09%
EPS Growth
N/A
★ 9.67
EPS
N/A
★ 10.43
Revenue
N/A
★ $2,957,013,000.00
Revenue This Year
$3.66
$2.59
Revenue Next Year
$5.68
$6.92
P/E Ratio
★ $12.93
$23.25
Revenue Growth
N/A
★ 13.44
52 Week Low
$24.19
$180.27
52 Week High
$42.39
$277.67

Technical Indicators

Market Signals
Indicator
IX
RMD
Relative Strength Index (RSI) 39.20 66.40
Support Level $35.68 $217.41
Resistance Level $37.04 $242.40
Average True Range (ATR) 0.45 4.63
MACD -0.05 1.94
Stochastic Oscillator 43.17 85.93

Price Performance

Historical Comparison
IX
RMD

About IX Orix Corp Ads

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: